Age dependent type 1 diabetes pathogenesis

Slides:



Advertisements
Similar presentations
بسم الله الرحمن الرحيم. Immunological markers in the pathogenesis of type 1 diabetes in Saudi children.
Advertisements

Immune system, Organ Transplants and Blood Chapter 13.
Chapter15 B cell mediated immune response. B cells mediated immune response Humoral immunity(HI) or antibody mediated immunity: The total immunological.
Rituximab Selectively Suppresses Specific Islet Antibodies Trialnet-Yu et al Diabetes 2011.
Pathophysiology of Type 1 Diabetes
Who gets the autoimmune disease Type 1 diabetes, and why? 35 years of Type 1 diabetes immunology research – an autoimmune disease model emerges How genes.
1 Diagnosis of Type 1 Diabetes. 2 Classifying Diabetes IAA, autoantibodies to insulin; GADA, glutamic acid decarboxylase; IA-2A, the tyrosine phosphatase.
Progressive Loss C-peptide Post Diagnosis (SEARCH Diab Care 2009) DCCT Fast>=.23ng/ml.
“Stages” in Development of Type 1A Diabetes Age (years) Genetic Predisposition Beta cell mass (?Precipitating Event) Overt immunologic abnormalities Normal.
ANTIBODIES VARIABILITY IN TYPE 1 DIABETES-Clinical implications? Dr M A LAMKI Senior Consult. Endocrinologist Royal hosp.Oman.
Lecture 3 clinical immunology Antigen Presenting Cells
R2=.37 P
Diabetes mellitus Dr. Essam H. Jiffri.
Keystone Diabetes in Youth Snowmass: Jan 23, 2008 Clinical diabetes and Endocrinology Book on Immunology Diabetes With teaching.
Unless otherwise noted, the content of this course material is licensed under a Creative Commons Attribution - Non- Commercial - Share Alike 3.0 License.
Chapter 18 Autoimmune Diseases 1. 1.Immunological homeostasis: To self Ag, our immune system is in tolerance and immune response won’t take place. Immune.
The Molecular face of red cells.  Refers to the detection of the molecular basis of an antigen rather than the antigen itself  Prerequisites:  Knowledge.
Chapter 11 Prediction of Type 1A Diabetes: The Natural History of the Prediabetic Period.
Lecture 22 Autoimmunity.
Autoimmune Insulin-dependent diabetes mellitus (Type 1): (IDDM-type 1)
1 The Burden of Type 1 Diabetes. 2 Incidence and Prevalence of Type 1 Diabetes Type 1 diabetes mellitus (T1DM) is the major type of diabetes in youth.
The effect of TCDD on cytokine production during the progression of insulitis in NOD mice Tuan Pham Dr. Nancy Kerkvliet Environmental and Molecular Toxicology.
Genes, Environment- Lifestyle, and Common Diseases Chapter 5.
Immunology Chapter 20 Richard L. Myers, Ph.D. Department of Biology
Introduction Function of the Endocrine Pancreas Insulin Glucagon Incretins Somatostatin Diabetes Mellitus Type 1 Diabetes Type 2 Diabetes Measures of.
DIABETES MELLITUS PATHOGENESIS, CLASSIFICATION, DIAGNOSIS.
Note No cow’s milk or cow’s milk products (including but not limited to cheese and yoghurt) under the age of one year -casein (a protein in cow’s milk)
The Autoimmune insulin-dependent Diabetes mellitus: Major immunologic Features: 1- HLA-DR3 and DR4 haplotype expression on the beta cells of the islets.
Endocrine Diseases: Mechanism of development of Autoimmune endocrine disease: Two factors could be involved in development of human autoimmune disorders:
Natural History of Type 1 Diabetes CELLULAR (T CELL) AUTOIMMUNITY LOSS OF FIRST PHASE INSULIN RESPONSE (IVGTT) (IVGTT) GLUCOSE INTOLERANCE (OGTT) HUMORAL.
DIAGNOSIS OF HIV INFECTION THE LABORATORY BY DR. K.BUJJIBABU.MD.
Removal of Bovine Insulin From Cow’s Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study Vaarala O, Ilonen J, Ruohtula.
Pathophysiology of Type 1 Diabetes 1. Type 1 Diabetes Mellitus Characterized by absolute insulin deficiency Pathophysiology and etiology –Result of pancreatic.
The genetic bases BY Casey Jaroche
Hypothesis 1: Chimerism induces a graft-versus-host reaction Host B lymphocyte B B B B Chimeric Th lymphocyte Chimeric CTL Stimulation No elimination or.
Marco Songini on behalf of the Sardinian IDDM Study Groups The Type 1 Diabetes Sardinia (Hot&Cold Spot) Project: what did we learn so far?
1 Genes, Environment- Lifestyle, and Common Diseases Chapter 5.
Part B Autoimmune Diseases Part B Autoimmune Diseases Effector mechanisms of autoimmune disease Endocrine glands as special targets.
AUTOIMMUNITY. Self/Non-self Discrimination Autoimmunity is a problem of self/non-self discrimination.
Immunology molecular medicine 3 Conleth Feighery.
Autoimmunity and Type I Diabetes CCMD 793A: Fundamental Integrated SystemsFALL, 2006 James M. Sheil, Ph.D.
Autoimmune Insulin Dependent Diabetes Mellitus (Type 1 Diabetes Mellitus) :
Genetic Testing and the Prevention of Type 1 Diabetes Janice S. Dorman, Ph.D. September 4, 2001.
Role of CTLA-4 polymorphism in susceptibility to type 1 diabetes: Results of a family and a case-control study in Southern Tunisia Immunology Department,
In The Name of GOD Genetic Polymorphism M.Dianatpour MLD,PHD.
Note Nutrition 101 tutor TUTOR REQUIRED FOR NUTRITION CONTACT DR. BARRE IF YOU OR SOMEONE ELSE ARE INTERESTED. A student tutoring for the Jennifer.
Proposed Guidelines on Genetic Screening for Type 1 Diabetes Screening by determining HLA type is not currently warranted outside the context of defined.
The Immune System and Endocrine Disorders
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS.
PATHOGENESIS AND RESEARCH FOR THE PREVENTION OF TYPE 1 DIABETES MELLITUS NATALIA BOWAKIM ANTA.
Diagnosing Diabetes In Adults– Type 1, LADA, or Type 2? Stanley Schwartz MD, FACE, FACP Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. of Medicine.
Pathogenesis and biological interventions in T1DM- LIKE autoimmune diabetes- Insulitis The class I MHC molecules are hyperexpressed on the β-cell surface.
DIPP-aineiston hallinnan ja avaamisen haasteet DIPP – Finnish Type 1 Diabetes Prediction and Prevention Study Jorma Toppari University of Turku Tämä teos.
Pathophysiology of Type 1 Diabetes
Autoimmune diseases Ch. 4 p (99 – 159) March 7 /2016 March
“Systemic Lupus Erythematosus” (SLE): Pathophysiology
Key research: Van Leeuwen et al
“Systemic Lupus Erythematosus” (SLE)
Young Children with Type 1 Diabetes Mellitus Have Low Rate of Partial Remission Sasigarn A. Bowden, Mary Duck, Robert P Hoffman Division of Endocrinology,
Immunological Tolerance and Autoimmune Diseases
Major immunologic Features:
Type-I Diabetes Seth Cressey Steven Moore Nov 2012.
TYPE 1 DIABETES MELLITUS
Nat. Rev. Endocrinol. doi: /nrendo
Genetic Testing and the Prevention of Type 1 Diabetes
ANTIBODIES VARIABILITY IN TYPE 1 DIABETES-Clinical implications?
Prediction and Pathogenesis in Type 1 Diabetes
The Autoimmune insulin-dependent Diabetes mellitus:
Autoimmunity Semester : III Course Title : Immunology Unit : III
Defining antigen-specific responses with human MHC class II tetramers
Presentation transcript:

Age dependent type 1 diabetes pathogenesis Ake Lernmark

From Joerg Ermann & C. Garrison Fathman Nature Immunology 2, 759 - 761 (2001)

Insulitis

Type 1 diabetes genes v HLA DQ2, DQ8, or both, represents almost 90% of all type 1 diabetes patients younger than 20 years of age. The risk of DQ2/8 heterozygotes decreases with increasing age. The protection of DQ6.2 is attenuated by increasing age and is lost at about 35 years of age. v v v Class I - INS VNTR -short tandem repeats - increase the risk by about 2-5 %. v CTLA-4 - long AT-repeats at the 5’ end UTR - increase the risk by about 2-3%.

ENVIRONMENTAL FACTORS * MONOZYGOTIC TWINS 20-30% CONCORDANCE. ** ONLY 10-15% OF NEW PATIENTS HAVE A PARENT OR SIBLING WITH THE DISEASE. VIRUS: MUMPS,COXSACKIE, RUBELLA, ECHO, ROTA, LJUNGAN AND OTHERS. FOOD ITEMS: NITROSAMINES, MILK PROTEINS GESTATIONAL INFECTIONS AND ABO INCOMPATIBILITY

VIRUS AND TYPE 1 DIABETES Coxsackie Human, mice (Yoon) Rubella Human, hamster Mumps Human Cytomegalovirus Human Rotavirus Human CBV4 T cell activation (Vbeta analysis): T1DM=controls (Varela-Calvino et al. 2001) CBV4 T cell proliferation: T1DM > controls (Juhela et al 2000) CBV4-specific T-cell epitopes: T1DM = controls (Martilla et al. 2001) No or little cross reactivity between molecular mimicry regions (Several authors)

ABO and hyperbilirubinemia Autoantibody Controls ABO immunization Hyperbilirubinemia IA-2Ab 1,4% (4/288) 6,6% (10/151)* 1,6% (5/311) GAD65Ab 1,6% (5/320) 2,6% (4/151) 1,3% (4/311) ICA 0,6% (2/320) 4,0% (6/151)** 4,2% (13/311)*** Difference compared to controls: * p=0.007; ** p=0.015; *** p=0.003. All samples are cord blood.

R R R R R GENETIC EFFECTS ON AGE-DEPENDENT ONSET AND ISLET CELL ANTIBODIES IN TYPE 1 DIABETES. R PATIENTS: INCIDENT, 0-34 YEARS OF AGE n=971 R CONTROLS: MATCHED FOR AGE AND GENDER n=702 R HLA, INS VNTR AND CTLA-4 R GAD65A, IA-2A, IAA AND ICA LOGISTIC REGRESSION TO MODEL THE NATURAL LOGARITHM OF THE ODDS R

RISK FOR TYPE 1 DIABETES AS FUNCTION OF AGE, GENDER, HLA AND GAD65A. THE ODDS TO DEVELOP TYPE 1 DIABETES: A FEMALE WITH GAD65Ab HAS 3 TIMES THE RISK OF A MALE. COMPARED TO A FIVE YEAR OLD WITH GAD65Ab BUT NO DQ2: 3 TIMES HIGHER RISK WITH ONE DQ2 8 TIMES HIGHER RISK WITH TWO DQ2 DQ2 DOES NOT AFFECT THE RISK FOR A GAD65AB POSITIVE 34 YEAR OLD

RISK FOR TYPE 1 DIABETES AS FUNCTION OF AGE, GENDER, HLA, AND IA-2Ab. THE ODDS FOR TYPE 1 DIABETES WITH IA-2Ab AT 5 YEARS OF AGE IS 11 TIMES THAT AT 34 YEARS OF AGE. THE ODDS FOR EACH ADDITIONAL DQ8: 1.5 TIMES FOR ONE DQ8 3.0 TIMES FOR TWO DQ8 THE ODDS OF EACH ADDITIONAL DQ2: DECREASES 0.27 TIMES FOR ONE DQ2 0.6 TIMES FOR TWO DQ2

Insulin autoantibodies are associated with a combination of HLA-DQ8 and INS VNTR. Click for larger picture

RISK FOR TYPE 1 DIABETES AS FUNCTION OF AGE, GENDER, HLA, INS VNTR AND IAA. THE ODDS FOR TYPE 1 DIABETES WITH IAA AT 5 YEARS OF AGE IS 10 TIMES THAT AT 34 YEARS OF AGE. THE ODDS FOR EACH ADDITIONAL DQ8: 1.4 TIMES FOR ONE DQ8 2.1 TIMES FOR TWO DQ8 THE ODDS OF EACH ADDITIONAL INS VNTR CLASS I ALLELE: 1.5 TIMES FOR ONE CLASS I 2.2 TIMES FOR TWO CLASS I

SUMMARY, SO FAR……... * MULTIPLE ENVIRONMENTAL FACTORS. *GESTATIONAL EFFECTS. * HLA HAS THE MAJOR GENETIC EFFECT - INS VNTR AND OTHER GENETIC FACTORS CONTRIBUTE. * AGE-DEPENDENT EFFECTS OF HLA AND ON GAD65Ab IAA - INS VNTR CONTRIBUTES IA-2Ab * USEFUL INFORMATION FOR PREDICTION?

COMBINATIONS OF ISLET CELL AUTO-ANTIBODIES PREDICT TYPE 1 DIABETES Click for larger picture

WHAT ABOUT CHILDREN AND TEENAGERS? * WASHINGTON PREDICTION STUDY: > 4 500 14 year olds were screened Follow up 9 years. All 15 children developing diabetes were predicted. No false negatives. No false positives. Hagopian et al. Diabetes Care 2002 * SCREENING NEWBORNS: HLA and antibodies DIPP (Finland), TRIGR (international), DAISY (Denver, CO), PANDA (Gainesville, FL), ABIS (South East Sweden), DiPiS (South Sweden) MELBOURNE NEWBORN STUDY

TYPE 1 DIABETES IS A T-CELL MEDIATED DISEASE * Poor antigen quality has hampered novel technologies to detect T-cells reactive with GAD65, proinsulin (PI), and IA-2. * The second T cell IDS workshop reported GAD65 (Diamyd Medical) generated in insect cells that stimulate relevant clones and does not inhibit third-party antigens. * A PI preparation generated in bacteria was free of effects on proliferation to third-party antigens and low in endotoxin. * These preparations should be useful to develop robust and sensitive assays of autoantigen-specific T cells that predict diseases. * Peakman et al. Report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays. Diabetes 50:1749-54, 2001.

GAD65Ab modulate GAD65 antigen presentation. T-cell hybridomas DRB1*0401 restricted GAD65 peptide 274-286 dependent APC from DRB1*0401 subjects IL-2 release response GAD65Ab positive sera from new onset children at various end-point titers Reijonen et al Diabetes 2001

IL-2 concentration(U/ml) 0,0 2,5 5,0 7,5 10,0 12,5 0,0 0,25 0,5 0,75 1,0 1,25 IL-2 concentration(U/ml) GAD65 antibody index

ANTIBODY-MEDIATED POTENTIATION OF ANTIGEN-PRESENTATION. GAD65Ab mediated potentiation of antigen presentation may explain: Preservation of conformation dependent GAD65Ab before diagnosis. Preservation of conformation dependent GAD65Ab after diagnosis when beta cells are gone. Acceleration of beta cell destruction by recruiting new CD4 and CD8 T cells.

SUMMARY AND CONCLUSIONS * HLA HAS THE MAJOR EFFECT - OTHER GENETIC FACTORS SUCH AS INS VNTR AND CTLA-4 CONTRIBUTE. * MULTIPLE ENVIRONMENTAL FACTORS. *GESTATIONAL EFFECTS. *EARLY T CELL RESPONSES ARE KEY TO INITIATION OF BETA CELL AUTOIMMUNITY. * AGE-DEPENDENT EFFECTS OF HLA AND ON GAD65Ab IAA INS VNTR CONTRIBUTE IA-2Ab. * CHRONIC BETA-CELL AUTOIMMUNITY MAY BE MAINTAINED BY AUTOANTIBODY-FACILITATED T CELL RESPONSES.

Acknowledgement JINKO GRAHAM NORMAN BRESLOW CHRISTIANE HAMPE LUO DONG HELENA REIJONEN GERALD T NEPOM SWEDISH DIABETES REGISTRIES FOR CHILDREN AND ADULTS CHRISTIANE HAMPE LUO DONG TERRI DANIELS LISA HAMMERLE STEN-A. IVARSSON CORRADO CILIO